These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 172657)

  • 21. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between cellular DNA- and histone synthesis following infection by cytomegalovirus in the presence of phosphonoacetic acid.
    Radsak K; Weder D
    Arch Virol; 1981; 68(3-4):313-20. PubMed ID: 6268023
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a herpesvirus saimiri-specified DNA polymerase activity which is aphidicolin-resistant and phosphonoacetate-sensitive.
    O'Hare P; Honess RW
    J Gen Virol; 1983 May; 64(Pt 5):1013-24. PubMed ID: 6302206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing cytomegalovirus, mycoplasma, and cellular DNA polymerases.
    Miller RL; Rapp F
    J Virol; 1976 Dec; 20(3):564-9. PubMed ID: 186634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides.
    Stinski MF
    J Virol; 1978 Jun; 26(3):686-701. PubMed ID: 209215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of activities of DNA polymerase alpha, beta, gamma, and reverse transcriptase of L1210 cells by phosphonoacetic acid.
    Allaudeen HS; Bertino JR
    Biochim Biophys Acta; 1978 Oct; 520(3):490-7. PubMed ID: 82450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication.
    Gadler H
    Antimicrob Agents Chemother; 1983 Sep; 24(3):370-4. PubMed ID: 6314892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of alpha type DNA polymerases in human cytomegalovirus-infected WI-38 cells.
    Hirai K; Watanabe Y
    Biochim Biophys Acta; 1976 Oct; 447(3):328-39. PubMed ID: 184838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
    Tyms AS; Davis JM; Clarke JR; Jeffries DJ
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1563-73. PubMed ID: 3035060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.
    Xiong X; Smith JL; Kim C; Huang ES; Chen MS
    Biochem Pharmacol; 1996 Jun; 51(11):1563-7. PubMed ID: 8630098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiherpesvirus action of phosphonoacetate.
    Boezi JA
    Pharmacol Ther; 1979; 4(1):231-43. PubMed ID: 88744
    [No Abstract]   [Full Text] [Related]  

  • 34. Human cytomegalovirus. III. Virus-induced DNA polymerase.
    Huang ES
    J Virol; 1975 Aug; 16(2):298-310. PubMed ID: 168404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate.
    Mao JC; Robishaw EE
    Biochemistry; 1975 Dec; 14(25):5475-9. PubMed ID: 53071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of phosphonoacetic acid on the in vitro replication of varicella-zoster virus.
    May DC; Miller MR; Rapp F
    Intervirology; 1977; 8(2):83-91. PubMed ID: 192695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1.
    Jofre JT; Schaffer PA; Parris DS
    J Virol; 1977 Sep; 23(3):833-6. PubMed ID: 197275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
    Otová B; Votruba I; Holý A
    Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis.
    Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E
    Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.